Positive Biotech Analyst Calls (AMGN, ATHX, DNA, GILD, SEPR)

June 19, 2008 · Filed Under General 

These are some of the upgrades and positive calls already being seen in the biotech sector this Thursday morning:

  • Amgen (NASDAQ: AMGN) Started as Buy at Deutsche Bank.
  • Athersys (NASDAQ: ATHX) started as Buy at Lazard Capital.
  • Genentech (NYSE: DNA) Started as Buy By Deutsche Bank.
  • Gilead (NASDAQ: GILD) Started as Buy at Deutsche Bank.
  • Sepracor (NASDAQ: SEPR) raised to Buy at UBS.

You can see the list of negative calls and downgrades here.

Jon Ogg
June 19, 2008

Tags: , , , , , ,

Comments

Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed